Skip to main content
. Author manuscript; available in PMC: 2012 Jul 1.
Published in final edited form as: Bone Marrow Transplant. 2011 Feb 28;47(1):65–72. doi: 10.1038/bmt.2011.16

Figure 1. Outcomes.

Figure 1

All curves are for the 27-patient population with a median follow-up of 35.7 months for survivors. Panel A shows the Kaplan-Meier estimate of survival probability. Panel B shows progression-free survival, defined as time from stem cell infusion to recurrence, progression, or death from any cause, whichever occurred first. Panel C shows cummulative incidence of relapse/progression, defined as time from stem cell infusion to recurrence or progression. Panel D shows non-relapse mortality, measured as time from stem cell infusion to death from any cause other than disease relapse or disease progression. In panels C and D, relapse/progression and non-relapse mortality were treated as competing risks.